CryoPort, Inc. (NASDAQ:CYRX) shares fell 12.9% during trading on Wednesday . The company traded as low as $8.00 and last traded at $8.27. 674,228 shares traded hands during mid-day trading, an increase of 171% from the average session volume of 248,600 shares. The stock had previously closed at $9.50.

A number of brokerages recently commented on CYRX. Janney Montgomery Scott set a $8.00 price target on CryoPort and gave the company a “buy” rating in a report on Wednesday, July 26th. Needham & Company LLC reissued a “buy” rating and issued a $6.00 price target (up previously from $4.50) on shares of CryoPort in a report on Monday, June 26th. Finally, Cowen and Company began coverage on CryoPort in a report on Friday, June 16th. They issued an “outperform” rating and a $5.50 price target for the company.

The firm’s market capitalization is $189.74 million. The company’s 50-day moving average price is $8.57 and its 200 day moving average price is $5.24.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings results on Tuesday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. CryoPort had a negative return on equity of 67.75% and a negative net margin of 102.89%. The firm had revenue of $2.92 million for the quarter, compared to analyst estimates of $2.84 million. On average, analysts forecast that CryoPort, Inc. will post ($0.72) EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently modified their holdings of CYRX. Taylor Wealth Management Partners bought a new position in CryoPort during the second quarter valued at about $1,851,000. Vanguard Group Inc. increased its stake in CryoPort by 96.9% during the second quarter. Vanguard Group Inc. now owns 519,100 shares of the company’s stock valued at $2,554,000 after acquiring an additional 255,519 shares during the period. EAM Investors LLC bought a new position in CryoPort during the second quarter valued at about $552,000. D.A. Davidson & CO. increased its stake in CryoPort by 16.6% during the second quarter. D.A. Davidson & CO. now owns 137,000 shares of the company’s stock valued at $674,000 after acquiring an additional 19,500 shares during the period. Finally, BerganKDV Wealth Management LLC increased its stake in CryoPort by 157.5% during the second quarter. BerganKDV Wealth Management LLC now owns 25,750 shares of the company’s stock valued at $127,000 after acquiring an additional 15,750 shares during the period. Hedge funds and other institutional investors own 12.05% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.thecerbatgem.com/2017/10/06/cryoport-inc-cyrx-shares-down-12-9.html.

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Stock Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related stocks with our FREE daily email newsletter.